Tumor regression patterns based on follow-up duration in patients with head and neck squamous cell carcinoma treated with radiotherapy or chemoradiotherapy

Clinical and Experimental Otorhinolaryngology

Volumn 8, Issue 4, 2015, Pages 416-421

  Kong, Moonkyoo ^a   Hong, Seong Eon ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

Carcinoma; Radiotherapy; Regression; Squamous cell of head and neck

Indexed keywords

EID: 84948140447     PISSN: 19768710     EISSN: 20050720     Source Type: Journal    
DOI: 10.3342/ceo.2015.8.4.416     Document Type: Article

References (15)

1. Dias FL. Assessment of treatment response after chemoradiation of head and neck cancer. Curr Oncol Rep. 2013Apr;15(2):119-27.
2. Jeong S, Yoo EJ, Kim JY, Han CW, Kim KJ, Kay CS. Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy. Radiat Oncol J. 2013 Dec;31(4):206-15.
3. Joshi A, Calman F, O’Connell M, Jeannon JP, Pracy P, Simo R. Current trends in the follow-up of head and neck cancer patients in the UK. Clin Oncol (R Coll Radiol). 2010 Mar;22(2):114-8.
4. de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg. 1994 Sep;120(9):934-9.
5. Cooney TR, Poulsen MG. Is routine follow-up useful after combinedmodality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg. 1999Apr;125(4):379-82.
6. Kothari P, Trinidade A, Hewitt RJ, Singh A, O’Flynn P. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients. EurArch Otorhinolaryngol. 2011Aug;268(8):1191-200.
7. Saito N, Nadgir RN, Nakahira M, Takahashi M, Uchino A, Kimura F, et al. Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know. Radiographics. 2012 Sep-Oct; 32(5):1261-82.
8. Lell M, Baum U, Greess H, Nomayr A, Nkenke E, Koester M, et al. Head and neck tumors: imaging recurrent tumor and post-therapeu tic changes with CT and MRI. Eur J Radiol. 2000 Mar;33(3):239-47.
9. Offiah C, Hall E. Post-treatment imaging appearances in head and neck cancer patients. Clin Radiol. 2011 Jan;66(1):13-24.
10. Mukherji SK, Wolf GT. Evaluation of head and neck squamous cell carcinoma after treatment.AJNRAm J Neuroradiol. 2003 Oct;24(9): 1743-6.
11. Ojiri H, Mendenhall WM, Mancuso AA. CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control. Int J Radiat Oncol Biol Phys. 2002 Mar;52(3):748-54.
12. Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM. Laryngeal or hypopharyngeal squamous cell carcinoma: can followup CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology. 2000 Mar;214(3): 683-7.
13. Passero VA, Branstetter BF, Shuai Y, Heron DE, Gibson MK, Lai SY, et al. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.Ann Oncol. 2010 Nov; 21(11):2278-83.
14. Sjovall J, Brun E, Almquist H, Kjellen E, Wahlberg P. Radiotherapy response in head and neck cancer - evaluation of the primary tumour site.Acta Otolaryngol. 2014 Jun;134(6):646-51.
15. Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005Aug;28(4):385-92.